Clinical trial
Comparison of Neonatal Outcomes With Two Dexamethasone Regimens (12 mg vs 6 mg Every 12 Hours) for Fetal Lung Maturation in Preterm Birth
NCT07765329 is registered in ClinicalTrials.gov with Stella Maris Women and Children Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Neonatal Outcomes With Two Dexamethasone Regimens (12 mg vs 6 mg Every 12 Hours) for Fetal Lung Maturation in Preterm Birth
- Lead sponsor
- Stella Maris Women and Children Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- June 1, 2026
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intraventricular hemorrhage (ivh), intraventricular hemorrhage neonatal, maternal infection during pregnancy, necrotizing enterocolitis (nec), neonatal hypoglycemia, neonatal respiratory distress syndrome, neonatal sepsis, neurodevelopmental disorder of foetus, premature birth, respiratory distress syndrome (rds)